Night shift work and breast cancer: a pooled analysis of population-based case–control studies with complete work history

Archive ouverte

Cordina-Duverger, Emilie | Menegaux, Florence | Popa, Alexandru | Rabstein, Sylvia | Harth, Volker | Pesch, Beate | Brüning, Thomas | Fritschi, Lin | Glass, Deborah C | Heyworth, Jane S | Erren, Thomas C | Castaño-Vinyals, Gemma | Papantoniou, Kyriaki | Espinosa, Ana | Kogevinas, Manolis | Grundy, Anne | Spinelli, John J | Aronson, Kristan J | Guénel, Pascal

Edité par CCSD ; Springer Verlag -

International audience. Night shift work has been suspected to increase breast cancer risk but epidemiological studies have been inconsistent due to heterogeneous assessment of exposure to night work. To overcome this limitation, we pooled data of five population-based case-control studies from Australia, Canada, France, Germany, and Spain into a single harmonized dataset using a common definition of night work including 6093 breast cancer cases and 6933 population controls. The odds ratio for breast cancer in women who ever worked at night for at least 3 h between midnight and 5 a.m. as compared to never night workers was 1.12 (95% CI 1.00-1.25). Among pre-menopausal women, this odds ratio was 1.26 [1.06-1.51], increasing to 1.36 [1.07-1.74] for night shifts ≥ 10 h, 1.80 [1.20-2.71] for work ≥ 3 nights/week, and 2.55 [1.03-6.30] for both duration of night work ≥ 10 years and exposure intensity ≥ 3 nights/week. Breast cancer risk in pre-menopausal women was higher in current or recent night workers (OR = 1.41 [1.06-1.88]) than in those who had stopped night work more than 2 years ago. Breast cancer in post-menopausal women was not associated with night work whatever the exposure metric. The increase in risk was restricted to ER+ tumors, particularly those who were both ER+ and HER2+ . These results support the hypothesis that night shift work increases the risk of breast cancer in pre-menopausal women, particularly those with high intensity and long duration of exposure. Risk difference between pre- and post-menopausal women deserves further scrutiny.

Suggestions

Du même auteur

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Archive ouverte | Michailidou, Kyriaki | CCSD

International audience. Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial risk of th...

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Archive ouverte | Liu, Jingjing | CCSD

International audience. In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. S...

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome–wide interaction study

Archive ouverte | Rudolph, Anja | CCSD

International audience. Women using menopausal hormone therapy (MHT) are at increased risk of developing breast cancer (BC). To detect genetic modifiers of the association between current use of MHT and BC risk, we ...

Chargement des enrichissements...